Published in Retina on September 01, 2012
Outer retinal structure after closed-globe blunt ocular trauma. Retina (2014) 1.01
Selective cone photoreceptor injury in acute macular neuroretinopathy. Retina (2013) 1.00
Association of Diabetic Macular Nonperfusion With Outer Retinal Disruption on Optical Coherence Tomography. JAMA Ophthalmol (2015) 0.96
Imaging of a cilioretinal artery embolisation. Int J Mol Sci (2014) 0.87
Deep Retinal Capillary Nonperfusion Is Associated With Photoreceptor Disruption in Diabetic Macular Ischemia. Am J Ophthalmol (2016) 0.84
CHARACTERIZATION OF THE MIDDLE CAPILLARY PLEXUS USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN HEALTHY AND DIABETIC EYES. Retina (2016) 0.81
Early features in acute macular neuroretinopathy. Int Ophthalmol (2013) 0.80
Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy. Graefes Arch Clin Exp Ophthalmol (2015) 0.78
IMAGING WITH MULTIMODAL ADAPTIVE-OPTICS OPTICAL COHERENCE TOMOGRAPHY IN MULTIPLE EVANESCENT WHITE DOT SYNDROME: THE STRUCTURE AND FUNCTIONAL RELATIONSHIP. Retin Cases Brief Rep (2016) 0.77
ENHANCED DEPTH IMAGING FEATURES OF A CHOROIDAL MACROVESSEL. Retin Cases Brief Rep (2016) 0.75
A patient with acute macular neuroretinopathy and central retinal vein occlusion. Clin Ophthalmol (2013) 0.75
Dengue Fever-Associated Maculopathy and Panuveitis in Australia. Case Rep Ophthalmol Med (2016) 0.75
Quantification of retinal layer thickness changes in acute macular neuroretinopathy. Br J Ophthalmol (2016) 0.75
Optical Coherence Tomography Angiography of Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy. JAMA Ophthalmol (2015) 0.75
Sudden-onset paracentral vision loss. JAMA Ophthalmol (2014) 0.75
Acute macular neuroretinopathy following rhinosurgery. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
Acute macular neuroretinopathy misdiagnosed as optic neuritis. Int Ophthalmol (2014) 0.75
Acute macular neuroretinopathy associated with subclinical cytomegalovirus infection. Int Ophthalmol (2016) 0.75
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology (2010) 3.49
Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology (2012) 3.35
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33
Idiopathic multifocal choroiditis/punctate inner choroidopathy with acute photoreceptor loss or dysfunction out of proportion to clinically visible lesions. Retina (2015) 3.26
Extreme choroidal thinning in high myopia. Retina (2015) 3.23
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation. Br J Ophthalmol (2011) 2.80
Diagnostic and therapeutic challenges. Retina (2006) 2.80
Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. JAMA Ophthalmol (2013) 2.48
Characterization of birdshot chorioretinopathy using extramacular enhanced depth optical coherence tomography. JAMA Ophthalmol (2013) 2.36
The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology (2013) 2.35
Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration. Am J Ophthalmol (2013) 2.32
Signal strength is an important determinant of accuracy of nerve fiber layer thickness measurement by optical coherence tomography. J Glaucoma (2009) 2.19
Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV. Graefes Arch Clin Exp Ophthalmol (2010) 2.16
Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy. JAMA Ophthalmol (2013) 2.15
Chronic retinal necrosis: cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients. Retina (2013) 2.12
The expanded spectrum of focal choroidal excavation. Arch Ophthalmol (2011) 2.11
Atypical presentations of multiple evanescent white dot syndrome without white dots: a case series. Retina (2011) 2.09
Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26. Arch Ophthalmol (2005) 2.05
RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Retina (2015) 1.99
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98
Tears of the retinal pigment epithelium: an old problem in a new era. Retina (2007) 1.96
Images in clinical medicine. Medical mystery--visual-field defect. N Engl J Med (2006) 1.95
Factors associated with variability in retinal nerve fiber layer thickness measurements obtained by optical coherence tomography. Ophthalmology (2007) 1.91
Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol (2007) 1.89
Infectious endophthalmitis after intravitreal injection of antiangiogenic agents. Retina (2009) 1.88
Retinal thickness analysis by race, gender, and age using Stratus OCT. Am J Ophthalmol (2009) 1.86
Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. Ophthalmology (2005) 1.80
Paracentral acute middle maculopathy: a new variant of acute macular neuroretinopathy associated with retinal capillary ischemia. JAMA Ophthalmol (2013) 1.76
Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion. Retina (2014) 1.70
Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol (2011) 1.68
Persistent placoid maculopathy: a new clinical entity. Ophthalmology (2007) 1.66
Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology (2007) 1.66
Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol (2010) 1.65
Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial. Ophthalmology (2011) 1.62
Silicone oil retention sutures in aphakic eyes with iris loss. Arch Ophthalmol (2010) 1.62
Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): new observations and a proposed staging system. Ophthalmology (2007) 1.62
Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina (2002) 1.60
Photodynamic therapy of choroidal hemangioma in sturge-weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas. Surv Ophthalmol (2010) 1.56
Special requirements for electronic health record systems in ophthalmology. Ophthalmology (2011) 1.51
Mifepristone treatment of chronic central serous chorioretinopathy. Retina (2007) 1.48
Evaluation of age-related macular degeneration with optical coherence tomography. Surv Ophthalmol (2012) 1.47
Characterization of cytokine responses to retinal detachment in rats. Mol Vis (2006) 1.43
Immunosuppression for autoimmune retinopathy. Arch Ophthalmol (2009) 1.43
The case for observational management of suspected small choroidal melanoma. Arch Ophthalmol (2006) 1.43
Evaluating teaching methods of cataract surgery: validation of an evaluation tool for assessing surgical technique of capsulorhexis. J Cataract Refract Surg (2012) 1.42
Factors affecting DSAEK graft lenticle adhesion: an in vitro experimental study. Cornea (2014) 1.42
Is coxsackievirus the cause of unilateral acute idiopathic maculopathy? Arch Ophthalmol (2004) 1.41
Optical coherence tomography use in evaluation of the vitreoretinal interface: a review. Surv Ophthalmol (2007) 1.41
Medical mystery: visual-field defect--the answer. N Engl J Med (2006) 1.40
Glaucoma and intravitreal steroids. Ophthalmology (2005) 1.39
Modification of silicone oil retention sutures in aphakic eyes with iris loss-reply;. Arch Ophthalmol (2012) 1.38
SD OCT features of dry arcuate longstanding retinal folds. Eur J Ophthalmol (2011) 1.38
Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology (2010) 1.38
Persisent ocular hypertension following intravitreal ranibizumab. Graefes Arch Clin Exp Ophthalmol (2008) 1.37
Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model. Am J Ophthalmol (2006) 1.37
Review of genetics in age related macular degeneration. Semin Ophthalmol (2007) 1.37
Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.36
Punctate inner choroidopathy: a survey analysis of 77 persons. Ophthalmology (2007) 1.36
Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies. Ophthalmology (2002) 1.36
Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Nat Genet (2010) 1.35
Epidemiology and course of disease in childhood uveitis. Ophthalmology (2009) 1.35
Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature. Cornea (2007) 1.34
Preliminary 6 month results from the Argus II epiretinal prosthesis feasibility study. Conf Proc IEEE Eng Med Biol Soc (2009) 1.34
Sympathetic ophthalmia: incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol (2009) 1.33
Crystalline retinopathies. Surv Ophthalmol (2006) 1.33
Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.33
Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. JAMA Ophthalmol (2013) 1.33
Solar retinopathy: comparison of optical coherence tomography (OCT) and fluorescein angiography (FA). Retina (2009) 1.31
Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing. Retina (2006) 1.30
Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis. Arch Ophthalmol (2011) 1.29
Ocular disease in pregnancy. Curr Opin Ophthalmol (2005) 1.28
Spatial distribution of posterior pole choroidal thickness by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2011) 1.28
Ultra-wide-field and autofluorescence imaging of choroidal dystrophies. Ophthalmic Surg Lasers Imaging (2010) 1.26
Macular schisis and detachment associated with presumed acquired enlarged optic nerve head cups. Am J Ophthalmol (2007) 1.26
Optic neuritis associated with adalimumab in the treatment of uveitis. Ocul Immunol Inflamm (2010) 1.26
Predictors of anti-VEGF-associated retinal pigment epithelial tear using FA and OCT analysis. Retina (2008) 1.26
Relationship among visual field, blood flow, and neural structure measurements in glaucoma. Invest Ophthalmol Vis Sci (2012) 1.25
Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci (2009) 1.23
Systemic and intraocular manifestations of West Nile virus infection. Surv Ophthalmol (2004) 1.22
Changes in retinal sensitivity from retained subretinal perfluorocarbon liquid. Retina (2009) 1.22
The use of ultra wide field fluorescein angiography in evaluation and management of uveitis. Semin Ophthalmol (2009) 1.21
Paraneoplastic and non-paraneoplastic retinopathy and optic neuropathy: evaluation and management. Surv Ophthalmol (2013) 1.19
Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol (2007) 1.17
Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology (2008) 1.15
Comparison of clinically relevant findings from high-speed fourier-domain and conventional time-domain optical coherence tomography. Am J Ophthalmol (2009) 1.15
Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina (2014) 1.15
Effects on the contralateral eye after intravitreal bevacizumab and ranibizumab injections: a case report. Ann Acad Med Singapore (2008) 1.15
Pharmacologic therapy of pseudophakic cystoid macular edema: 2010 update. Retina (2011) 1.13
Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial. Ophthalmology (2009) 1.13
Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy. Retina (2014) 1.12
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology (2013) 1.12
Sustained elevated intraocular pressures after intravitreal injection of bevacizumab, ranibizumab, and pegaptanib. Retina (2011) 1.11
Retinal and optic nerve diseases. Artif Organs (2003) 1.10
Long-term follow-up of acute retinal necrosis. Retina (2010) 1.09
Dexamethasone for ocular inflammation. Expert Opin Pharmacother (2011) 1.08
Torpedo maculopathy. Br J Ophthalmol (2009) 1.08